Nathan Treybeck
Stock Analyst at Wells Fargo
(0.73)
# 3,859
Out of 4,423 analysts
63
Total ratings
28.9%
Success rate
-4.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Nathan Treybeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RMD ResMed | Rated: Hold | $227 | $188.63 | +20.34% | 2 | May 29, 2026 | |
| PRCT PROCEPT BioRobotics | Maintained: Buy | $34 | $21.72 | +56.54% | 24 | Mar 20, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Hold | $93 → $94 | $93.95 | +0.05% | 7 | Feb 26, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | $225 → $200 | $104.65 | +91.11% | 19 | Feb 20, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $132 → $80 | $90.96 | -12.05% | 11 | Oct 23, 2025 |
ResMed
May 29, 2026
Rated: Hold
Price Target: $227
Current: $188.63
Upside: +20.34%
PROCEPT BioRobotics
Mar 20, 2026
Maintained: Buy
Price Target: $34
Current: $21.72
Upside: +56.54%
LeMaitre Vascular
Feb 26, 2026
Maintained: Hold
Price Target: $93 → $94
Current: $93.95
Upside: +0.05%
iRhythm Holdings
Feb 20, 2026
Maintained: Buy
Price Target: $225 → $200
Current: $104.65
Upside: +91.11%
Integer Holdings
Oct 23, 2025
Downgraded: Hold
Price Target: $132 → $80
Current: $90.96
Upside: -12.05%